Skip to content

Clinical trials

Hyperglycemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Country / region: China Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20145
20162
20171
20181
20192
20203
20211
20223
20233
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status7
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Huazhong University of Science and Technology2
Novartis Pharmaceuticals2
Shanghai Zhongshan Hospital2
Sun Yat-sen University2
Westlake University2
Yabao Pharmaceutical Group2
Anhui Medical University1
B & Y Technologies1
Capital Medical University1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia29
Diabetes Mellitus5
Diabetes Mellitus, Type 25
Insulin Resistance4
Critical Illness3
Hyperlipidemias3
Hypertension3
Obesity3
Glucose Metabolism Disorders2
Acromegaly1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.